Abstract 724: Preclinical evaluation of TQB3728, a potent orally active IAP antagonist

Authors: Yingchun Liu, Xiquan Zhang, Ling Yang, Xin Tian, Tiantian Dong, Charles Z. Ding, Lihong Hu, Zhaobing Xu, Yuanfeng Xia, Haijuan Tong, Wenxi Li, Lijuan Hou, Chichung Chan, Shuhui Chen

Published: 2019-08-07

DOI: 10.1158/1538-7445.am2019-724

Source: Full article